top of page
Chemical works

Current Projects Funded
by NDR

2021-2022 Term

David Borchelt

Testing ALS drug synergy in ALS mouse models

Matt Farrer &
Rejko Krueger

CRISPR modified mouse targeting ALS associated metabolic pathways

Susanne
Petri

Investigating the therapeutic potential of drug interventions on the microglia in ALS mouse models

Peng Jin

Epigenetics in ALS patients

Lauren Kokai

Drug efficacy in ALS cell dysfunctional assay; Develop dynamic therapeutic systems

Sayuri Miyamoto

Lipidomics and lipid marker discovery from ALS tissues

Gerardo Morfini

Axon transport and phosphokinase signaling in ALS models

Steven Pelech

Phosphosite antibody reagent development for ALS biomarker discovery

Allen Reitz

Levamisole and thymopoietin drug analogs

Mohtashim Shamsi

Disease detection by wax-on-paper sensors

Chris Shaw

Biomarker detection in mice and humans

Teepu Siddique

Regulating protein processing and drug development; ALS commons

Chandler Walker

Restore muscle mass in ALS patients; ASC-CM for ALS therapy

Jessica Morrice

Drugs efficacy in normal cell functional assays, cytokine responses

Robert Naviaux & Robert Pascuzzi

bottom of page